PARKINSONS DISEASE THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Table of Contents (Version-2026)

1. Research Objective and Assumption

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Drug Class
     • Market Snippet, By Route of Administration
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
     • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • • Market Dynamics
       • Drivers
       • Restraints
       • Market Opportunities
     • Impact Analysis
     • Recent Test Launches
     • Epidemiology
     • Merger, Acquisition, and Collaborations
     • Regulatory Scenario
     • Key Developments
     • PEST Analysis

4. Global Parkinsons Disease Therapeutics Market, By Drug Class, 2021– 2033, (US$ Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022–2033
     • Segment Trends
   • Levodopa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Bn)
     • Segment Trends
   • Dopamine agonists
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
     • Segment Trends
   • MAO-B inhibitors
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
     • Segment Trends
   • Anticholinergics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
     • Segment Trends
   • Others (Catechol-O-methyl transferase [COMT] inhibitors and amantadine, among Others)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
     • Segment Trends

5. Global Parkinsons Disease Therapeutics Market, By Route of Administration, 2021–2033, (US$ Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022–2033
     • Segment Trends
   • Oral
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
     • Segment Trends
   • Injectable
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
     • Segment Trends
   • Nasal
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
     • Segment Trends
   • Transdermal
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
     • Segment Trends
   • Others (Rectal, Sublingual, among Others)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
     • Segment Trends

6. Global Parkinsons Disease Therapeutics Market, By Distribution Channel, 2021–2033, (US$ Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022–2033
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)

7. Global Parkinsons Disease Therapeutics Market, By Region, 2021–2033, (US$ Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022–2033
     • Segment Trends
   • North America
     • Introduction
     • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 –2033, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 –2033, (US$ Bn)
     • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
       • U.S.
       • Canada
   • Europe
     • Introduction
     • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 –2033, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 –2033, (US$ Bn)
     • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
       • U.K.
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 –2033, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 –2033, (US$ Bn)
     • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
       • China
       • India
       • Japan
       • ASEAN
       • Australia
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Introduction
     • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 –2033, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 –2033, (US$ Bn)
     • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Middle East
     • Introduction
     • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 –2033, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 –2033, (US$ Bn)
     • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 –2033, (US$ Bn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 –2033, (US$ Bn)
     • `Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 –2033, (US$ Bn)
     • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021–2033, (US$ Bn)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region,  2021 –2033, (US$ Bn)
       • North Africa
       • Central Africa
       • South Africa

8. Competitive Landscape

   • Company Profiles
     • Teva Pharmaceutical Industries Ltd.*
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Novartis AG
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • GlaxoSmithKline Plc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • AbbVie Inc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Merck & Co., Inc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Zydus Cadila
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Dr. Reddy’s Laboratories
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Sun Pharmaceutical Industries Ltd.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Cipla Inc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Boehringer Ingelheim International GmbH
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Denali Therapeutics Inc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Biogen Inc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Prevail Therapeutics
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Eli Lilly and Company
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Voyager Therapeutics
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies

9. Section

   • References
   • Research Methodology
   • About us and Sales Contact

*Browse 39 market data tables and 23 figures on “Global Parkinsons Disease Therapeutics Market” – Global forecast to 2033